Los venados portan variantes de la COVID que ya no se ven en las personas
VIERNES, 3 de febrero de 2023 (HealthDay News) — Aunque las variantes de la COVID-19 alfa, gama y delta ya no circulan entre los humanos, continúan propagándose entre los venados de cola blanca.Estos animales son el mamífero grande más abundante en A…
Learn MoreLas publicaciones a favor de la marihuana en las redes sociales hacen que los adolescentes usen cannabis
VIERNES, 3 de febrero de 2023 (HealthDay News) — Las leyes prohíben la publicidad del cannabis dirigida a los adolescentes, pero esto no significa que siempre funcionen.En una nueva encuesta, los investigadores encontraron que los adolescentes de cua…
Learn MorePandemic-Linked Decline in Cancer Screening Persisted Into 2022
MONDAY, Feb. 6, 2023 (HealthDay News) — The decrease in cancer screening seen during the early stage of the COVID-19 pandemic persisted into 2022, according to a study published online Feb. 3 in JAMA Network Open.Christopher Doan, from the University…
Learn MoreCOVID-19 Leading Cause of Death for U.S. Children, Young People
MONDAY, Feb. 6, 2023 (HealthDay News) — COVID-19 was a leading cause of death among U.S. children and young persons (CYP) aged 0 to 19 years, according to a study published online Jan. 30 in JAMA Network Open.Seth Flaxman, Ph.D., from the University …
Learn MorePostop White Matter Injury Rates Down Over Time for Neonates With Complex CHD
MONDAY, Feb. 6, 2023 (HealthDay News) — For neonates with complex congenital heart disease (CHD), the rates of postoperative white matter injury (WMI) have decreased over time, according to a study published in the January issue of the Journal of the…
Learn MoreOutcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
MONDAY, Feb. 6, 2023 (HealthDay News) — Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in the morning, according to a st…
Learn MoreMomelotinib Yields Clinically Significant Improvement in Myelofibrosis
MONDAY, Feb. 6, 2023 (HealthDay News) — Treatment with momelotinib versus danazol yields clinically significant improvements for patients with myelofibrosis, according to a study published online Jan. 28 in The Lancet.Srdan Verstovsek, M.D., from the…
Learn MoreHundreds of U.S. Doctors Lost Their Lives During Pandemic
MONDAY, Feb. 6, 2023 (HealthDay News) — Many of America’s doctors who were heroes on the frontlines of the pandemic paid the ultimate price for their efforts, a new analysis shows.An estimated 622 extra deaths occurred among U.S. doctors aged 45 and …
Learn MoreGot Bunions? Key Factors to Whether Surgery Will Work for You
MONDAY, Feb. 6, 2023 (HealthDay News) — When it comes to bunions, millions of Americans are painfully familiar with the signs: Swelling, redness, a telltale bulge on the side of the big toe. Corns and calluses where other toes rub together. And pain….
Learn MoreMRI Might Boost Cancer Detection for Women With Dense Breasts
MONDAY, Feb. 6, 2023 (HealthDay News) — Nearly half of women have dense breast tissue, which can be a double whammy on their odds for breast cancer.Not only are dense breasts a risk factor for cancer, but this glandular and fibrous connective tissue …
Learn More